Log In
Print this Print this

Breast cancer vaccine (Ad5[E1-, E2b-]-HER2/neu)

  Manage Alerts
Collapse Summary General Information
Company Etubics Corp.
DescriptionVaccine using an adenovirus serotype 5 (Ad5) vector against HER2
Molecular Target Epidermal growth factor receptor 2 (HER2) (EGFR2) (ErbB2) (neu)
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector: Adenovirus
Latest Stage of DevelopmentPreclinical
Standard IndicationBreast cancer
Indication DetailsTreat breast cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today